329 related articles for article (PubMed ID: 10933070)
1. Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.
Mankoff DA; Dehdashti F; Shields AF
Neoplasia; 2000; 2(1-2):71-88. PubMed ID: 10933070
[TBL] [Abstract][Full Text] [Related]
2. Clinical oncological applications of Positron Emission Tomography (PET) using fluorine-18-fluoro-2-deoxy-D-glucose.
Giorgetti A; Volterrani D; Mariani G
Radiol Med; 2002 Apr; 103(4):293-318. PubMed ID: 12107381
[TBL] [Abstract][Full Text] [Related]
3. [Clinical usefulness of FDG-PET in oncology].
Sasaki M
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
[TBL] [Abstract][Full Text] [Related]
4. An introduction to PET-CT imaging.
Kapoor V; McCook BM; Torok FS
Radiographics; 2004; 24(2):523-43. PubMed ID: 15026598
[TBL] [Abstract][Full Text] [Related]
5. [New functional imaging technique "positron emission tomography"].
Tamaki N
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):101-4. PubMed ID: 9612703
[TBL] [Abstract][Full Text] [Related]
6. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
[TBL] [Abstract][Full Text] [Related]
7. [Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].
Comans EF; Hoekstra OS; Hoekman K; van der Hoeven JJ; Golding RP; Teule GJ
Ned Tijdschr Geneeskd; 2000 Aug; 144(32):1520-8. PubMed ID: 10949634
[TBL] [Abstract][Full Text] [Related]
8. Clinical role of FDG PET in evaluation of cancer patients.
Kostakoglu L; Agress H; Goldsmith SJ
Radiographics; 2003; 23(2):315-40; quiz 533. PubMed ID: 12640150
[TBL] [Abstract][Full Text] [Related]
9. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience.
Komori T; Narabayashi I; Matsumura K; Matsuki M; Akagi H; Ogura Y; Aga F; Adachi I
Ann Nucl Med; 2007 Jun; 21(4):209-15. PubMed ID: 17581719
[TBL] [Abstract][Full Text] [Related]
10. Whole-body imaging with PET/MRI.
Gaa J; Rummeny EJ; Seemann MD
Eur J Med Res; 2004 Jun; 9(6):309-12. PubMed ID: 15257872
[TBL] [Abstract][Full Text] [Related]
11. [Positron emission tomography in oncology].
Hatazawa J; Higuchi I; Nakamura H
Gan To Kagaku Ryoho; 2003 Jun; 30(6):748-54. PubMed ID: 12852339
[TBL] [Abstract][Full Text] [Related]
12. [Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].
Soepenberg O
Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1979-80. PubMed ID: 11048563
[No Abstract] [Full Text] [Related]
13. Positron emission tomography in cancer research and treatment.
Mandelkern M; Raines J
Technol Cancer Res Treat; 2002 Dec; 1(6):423-39. PubMed ID: 12625770
[TBL] [Abstract][Full Text] [Related]
14. Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma.
Karlan BY; Hawkins R; Hoh C; Lee M; Tse N; Cane P; Glaspy J
Gynecol Oncol; 1993 Nov; 51(2):175-81. PubMed ID: 8276290
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of positron emission tomography-computed tomography in oncology.
Kumar R; Halanaik D; Malhotra A
Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
[TBL] [Abstract][Full Text] [Related]
16. FDG PET/CT in oncology: "raising the bar".
Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
[TBL] [Abstract][Full Text] [Related]
17. [The contribution of PET to radiation treatment planning].
Belkacémi Y; Lartigau E; Kerrou K; Carpentier P; Taïeb S; Giraud P
Bull Cancer; 2007 Jan; 94(1):99-108. PubMed ID: 17237010
[TBL] [Abstract][Full Text] [Related]
18. PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.
Endo K; Oriuchi N; Higuchi T; Iida Y; Hanaoka H; Miyakubo M; Ishikita T; Koyama K
Int J Clin Oncol; 2006 Aug; 11(4):286-96. PubMed ID: 16937302
[TBL] [Abstract][Full Text] [Related]
19. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.
Roivainen A; Parkkola R; Yli-Kerttula T; Lehikoinen P; Viljanen T; Möttönen T; Nuutila P; Minn H
Arthritis Rheum; 2003 Nov; 48(11):3077-84. PubMed ID: 14613269
[TBL] [Abstract][Full Text] [Related]
20. [Present status of PET images: clinical FDG PET in oncology].
Inoue T
Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Nov; 59(13):737-44. PubMed ID: 10614103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
